AstraZeneca PLC (AZNCF)

149.300
+4.800(+3.32%)
After Hours
146.700
-2.600(-1.742%)
- Delayed Data
  • Volume:
    7,564
  • Bid/Ask:
    0.000/0.000
  • Day's Range:
    149.300 - 149.850

AZNCF Overview

Prev. Close
144.5
Day's Range
149.3-149.85
Revenue
43.84B
Open
149.85
52 wk Range
104.5-153.1
EPS
3.04
Volume
7,564
Market Cap
228.35B
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
4,947
P/E Ratio
47.66
Beta
0.175
1-Year Change
21.11%
Shares Outstanding
1,549,869,963
Next Earnings Date
26 Jul 2023
What is your sentiment on AstraZeneca?
or
Market is currently closed. Voting is open during market hours.

AstraZeneca PLC Company Profile

AstraZeneca PLC Company Profile

Employees
83500

AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The company’s marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Andexxa/Ondexxya, Atacand, Atacand HCT, Atacand Plus, Brilinta/Brilique, Bydureon/Byetta, BCise, Byetta, Crestor, Evrenzo, Farxiga/Forxiga, Komboglyze/Kombiglyze XR, Lokelma, Onglyza, Qtern, Xigduo/Xigduo, and Zestril XR for cardiovascular, renal, and metabolism diseases; Accolate, Accoleit, Vanticon, Bevespi Aerosphere, Breztri Aerosphere, Bricanyl Respules and Turbuhaler, Daliresp/Daxas, Duaklir Genuair, Fasenra, Pulmicort, Rhinocort, Saphnelo, Symbicort, and Tezspire for respiratory and immunology; and Kanuma, Soliris, Strensiq, and Ultomiris for rare diseases. Its marketed products also comprise Synagis for respiratory syncytial virus; Fluenz Tetra/FluMist Quadrivalent for Influenza; and Vaxzevria and Evusheld for covid-19. The company serves primary care and specialty care physicians through distributors and local representative offices in the United Kingdom, rest of Europe, the Americas, Asia, Africa, and Australasia. It has a collaboration agreement with Neurimmune AG to develop and commercialize NI006; and Personalis, Inc, as well as research collaboration with Sernova Corp. to evaluate novel potential therapeutic cell applications. The company was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in April 1999. AstraZeneca PLC was incorporated in 1992 and is headquartered in Cambridge, the United Kingdom.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyStrong BuyStrong BuyStrong BuyStrong Buy
Technical IndicatorsStrong BuyStrong BuyStrong BuyBuyStrong Buy
SummaryStrong BuyStrong BuyStrong BuyStrong BuyStrong Buy
  • hi
    0
    • If I don't know anything about this job now, please tell me everything
      0
      • Rizwan baig
        0
        • don't shorts from technical analysis informa will move from 11,158 to 11345.4 today target 🎯so buy quickly. don't short. if downtrend going then strongly buy.
          2
          • don't shorts from analysis AZN will move from now 11,158 today target 11345.78 easily movement🎯so buy quickly.
            1
            • iam new don't know anything doesnt even have a bank account can someone help?
              0
              • Get a bank account
                0
            • hi I'm new here please help
              0
              • I'm happy to trade with you
                1
                • good.., are you free 🙂
                  2
                  • yeh I am..
                    0
                • Just buy and hold it as long as u can
                  1